CPG for Eating Disorders

More documents

Recommendations

Info

427. Finnish Medical Society Duodecim. Eating disorders among children and adolescents. In: EBMGuidelines. Evidence-Based Medicine. Helsinki (Finland); 2004.428. Identifying and treating eating disorders. Pediatrics. 2003;111(1):204-11.429. Ebeling H, Tapanainen P, Joutsenoja A, Koskinen M, Morin-Papunen L, Jarvi L, et al. A practiceguideline for treatment of eating disorders in children and adolescents. Ann Med.2003;35(7):488-501.430. Thomas DR, Ashmen W, Morley JE, Evans WJ. Nutritional management in long-term care:development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care. JGerontol A Biol Sci Med Sci. 2000;55(12):M725-34.431. Eating disorders. Newcastle upon Tyne (United Kingdom): NHS Clinical Knowledge Summaries;2005.432. Allison KC, Crow SJ, Reeves RR, West DS, Foreyt JP, Dilillo VG, et al. Binge eating disorder andnight eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring).2007;15(5):1287-93.433. Lammers MW, Exterkate CC, De Jong CA.A Dutch day treatment program for anorexia and bulimianervosa in comparison with internationally described programmes. Eur Eat Disord Rev.2007;15(2):98-111.434. Cozzi F, Ostuzzi R. Relational competence and eating disorders. Eat Weight Disord.2007;12(2):101-7.435. Position of the American Dietetic Association: Nutrition intervention in the treatment of anorexianervosa, bulimia nervosa, and other eating disorders. J Am Diet Assoc.2006;106(12):2073-82.436. Signorini A, De Filippo E, Panico S, Pasanisi F, Contaldo F. Long-term mortality in anorexianervosa: a report after an 8-year follow-up and a review of the most recent literature. Eur J ClinNutr. 2007;61(1):119-22.437. Barabasz M. Efficacy of hypnotherapy in the treatment of eating disorders. Int J Clin ExpHypn. 2007;55(3):318-35.438. Wilson GT, Grilo CM, Vitousek KM. Psychological treatment of eating disorders. AmPsychol. 2007;62(3):199-216.439. Brandsma L. Eating disorders across the lifespan. J Women Aging. 2007;19(1-2):155-72.440. Kirkcaldy BD, Siefen GR, Kandel I, Merrick J. A review on eating disorders and adolescence.Minerva Pediatr. 2007;59(3):239-48.441. Carson JD, Bridges E. Abandoning routine body composition assessment: a strategy to reducedisordered eating among female athletes and dancers. Clin J Sport Med. 2001;11(4):280.442. Piran N. Prevention of eating disorders: a review of outcome evaluation research. Isr J PsychiatryRelat Sci. 2005;42(3):172-7.443. Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicineposition stand. The Female Athlete Triad. Med Sci Sports Exerc. 1997;29(5):i-ix.444. Stice E, Shaw H. Eating disorder prevention programmes: a meta-analytic review. Psychol Bull.2004;130(2):206-27.445. Austin SB. Prevention research in eating disorders: theory and new directions. Psychol Med.2000;30(6):1249-62.446. Claudino AM, Hay P, Lima MS, Bacaltchuk J, Schmidt U, Treasure J. Antidepressants for anorexianervosa. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004365.447. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L. Systems to rate the strength ofscientific evidence. Rockville, MD (US): Agency for Healthcare Research and Quality;2002. AHRQ Publication Nº. 02-EO16.286CLINICAL PRACTICE GUIDELINE FOR EATING DISORDERS
CLINICAL PRACTICE GUIDELINE FOR EATING DISORDERS287
Page 1 and 2:
Clinical Practice Guidelinefor Eati
Page 3:
This clinical practice guideline (C
Page 6 and 7:
Annex 2.7. Diagnostic Criteria for
Page 8 and 9:
This CPG aims to provide the popula
Page 11 and 12:
External Review of Patient Informat
Page 13 and 14:
14. What is the efficacy and safety
Page 15 and 16:
CLINICAL PRACTICE GUIDELINE FOR EAT
Page 17 and 18:
D 6.2. In anorexia nervosa (AN), we
Page 19 and 20:
D 8.6. Primary care centres should
Page 21 and 22:
9.GM.02. Before initiating artifici
Page 23 and 24:
Binge-Eating DisorderA 9.3.3.1. A s
Page 25 and 26:
D 9.GP.11. In children and adolesce
Page 27 and 28:
Binge-Eating DisorderD 9.GPH.6. In
Page 29 and 30:
11. Prognosis of Eating Disorders (
Page 31 and 32:
ED: Eating disorderEDNOS: Eating di
Page 33 and 34:
1. IntroductionBackgroundThe develo
Page 35 and 36:
However, there is a need for a guid
Page 37 and 38:
Table 2. Studies on the prevalence
Page 39 and 40:
2. Scope and ObjectivesTarget Popul
Page 41 and 42:
Aspects not included in the CPGThe
Page 43 and 44:
3. MethodologyThe methodology emplo
Page 45 and 46:
- Synthesis and analysis of the sci
Page 47 and 48:
4. Definition and Classification of
Page 49 and 50:
- Other psychopathological disturba
Page 51 and 52:
Sociocultural factorsThe studies id
Page 53 and 54:
accompany eating disorders. However
Page 55 and 56:
5. Prevention of Eating DisordersKe
Page 57 and 58:
(causal factors). Participants in t
Page 59 and 60:
is a programme that promotes a heal
Page 61 and 62:
MA 1341++MA 1341++No definitive con
Page 63 and 64:
Of all the proposed criteria and re
Page 65 and 66:
Spanish version of the EAT-40In Spa
Page 67 and 68:
of the five dimension results in th
Page 69 and 70:
6.5. It is recommended to use quest
Page 71 and 72:
7.2. How are eating disorders class
Page 73 and 74:
to help them cope with the situatio
Page 75 and 76:
Other examinationsTo ascertain whet
Page 77 and 78:
Page 79 and 80:
- Initiating nutritional treatment
Page 81 and 82:
8.2. In eating disorders, what clin
Page 83 and 84:
8.3.2. Criteria for admission to da
Page 85 and 86:
RecommendationsD 8.1. Individuals w
Page 87 and 88:
9. Treatment of Eating DisordersThe
Page 89 and 90:
An RCT (Rigaud, 2007; France) 203 c
Page 91 and 92:
9.2. Nutritional Counselling (NC)9.
Page 93 and 94:
Recommendations(See recommendations
Page 95 and 96:
Anorexia nervosaRecommendationsD 9.
Page 97 and 98:
PSYCHOLOGICAL THERAPIESIn this sect
Page 99 and 100:
Summary of the Evidence(See also th
Page 101 and 102:
There is limited evidence to sugges
Page 103 and 104:
In an RCT (Wilson, 2002; USA) 234 C
Page 105 and 106:
SRSE 2401++SRSE 2401++CBT treatment
Page 107 and 108:
In an RCT (Bulik, 1998) 236 the ove
Page 109 and 110:
Evidence indicates that it is unlik
Page 111 and 112:
A 9.3.3.1. Adult patients with BED
Page 113 and 114:
In an RCT (Carter, 2003; Canada) 24
Page 115 and 116:
Variable: reduction / remission of
Page 117 and 118:
In yet another RCT (Carter, 1998 26
Page 120 and 121:
Scientific EvidenceThere is insuffi
Page 122 and 123:
Recommendations(See also recommenda
Page 124 and 125:
Summary of the Evidence(See summary
Page 126 and 127:
In an RCT (Lock, 2005) 271 , 20% of
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
elaborated by the AHRQ of the US (2
Page 134 and 135:
SUMMARY OF THE EVIDENCE FORPSYCHOLO
Page 136 and 137:
D 9.GP.6. For patients with AN who
Page 138 and 139:
PHARMACOLOGICAL TREATMENTIn this se
Page 140 and 141:
9.9.1.2. What is the safety of anti
Page 142 and 143:
There is strong evidence that antid
Page 144 and 145:
Summary of the EvidenceSRSE 311++SR
Page 146 and 147:
There is insufficient evidence sugg
Page 148 and 149:
An RCT (Appolinario, 2003; Brazil)
Page 150 and 151:
9.10. AntipsychoticsEvidence in AN
Page 152 and 153:
9.11.2. What is the safety of cypro
Page 154 and 155:
9.13.1.2. What is the safety of top
Page 156 and 157:
Recommendations(See recommendations
Page 158 and 159:
SUMMARY OF THE EVIDENCE FORPHARMACO
Page 160 and 161:
COMBINED INTERVENTIONSThis section
Page 162 and 163:
Antidepressants vs. antidepressants
Page 164 and 165:
There is insufficient evidence to s
Page 166 and 167:
Summary of the EvidenceSRSE 311++SR
Page 168 and 169:
9.16.3. Binge-eating disorder9.16.3
Page 170 and 171:
TREATMENT OF EATING DISORDERS THATO
Page 172 and 173:
TREATMENT OF CHRONIC EATING DISORDE
Page 174 and 175:
10. Assessment of Eating DisordersK
Page 176 and 177:
EDI-2 (Version 2 of the EDI-1)Later
Page 178 and 179:
BIABody Image Assessment. Collins,
Page 180 and 181:
10.1.5. The use of questionnaires a
Page 182 and 183:
has been widely used. It consists o
Page 184 and 185:
out as the most adequate, given its
Page 186 and 187:
abuse/dependency, low sensation see
Page 188 and 189:
the freedom of articles 17 of the S
Page 190 and 191:
12.2. Is the informed consent of an
Page 192 and 193:
RecommendationAccording to current
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Algorithm 2. Intervention if there
Page 200 and 201:
9) Day care admission criteria:- Fr
Page 202 and 203:
- Oral nutritional support in eatin
Page 204 and 205:
Algorithm 4. Treatment of BN and BE
Page 206 and 207:
14.Dissemination and implementation
Page 208 and 209:
IntegralcareOutcomeSatisfaction ind
Page 210 and 211:
15. Future research recommendations
Page 212 and 213:
Annex 1. Levels of Evidence and Gra
Page 214 and 215:
Annex 2. Clinical chaptersAnnex 2.1
Page 216 and 217:
30. I eat diet food.31. I feel food
Page 218 and 219:
Annex 2.4. Spanish version of the C
Page 220 and 221:
6. Do you feel you have control ove
Page 222 and 223:
20. I feel sad after eating more th
Page 224 and 225:
33. APPLICABLE ONLY TO WOMEN. My la
Page 226 and 227:
12. Do you eat reasonable amounts o
Page 228 and 229:
Annex 2.7. Diagnostic Criteria for
Page 230 and 231:
Within each guideline some variatio
Page 232 and 233:
Bulimia nervosa (307.51)Diagnostic
Page 234 and 235:
Annex 2.8. Spanish version of the E
Page 236 and 237: Formula:Patients with eating disord
Page 238 and 239: Annex 3. Information for patients w
Page 240 and 241: Alert SignsWhat signs can alert us
Page 242 and 243: members can seek support and guidan
Page 244 and 245: therapist who guides the sessions a
Page 246 and 247: negative attitudes towards weight a
Page 248 and 249: PizotifenThis drug belongs to the g
Page 250 and 251: TopiramateAnticonvulsant psychoacti
Page 252 and 253: BULIT Bulimia TestBULIT-R Revised v
Page 254 and 255: ISCIII Carlos III Health InstituteI
Page 256 and 257: CLINICAL PRACTICE GUIDELINE FOR EAT
Page 258 and 259: General Directorate for Public Heal
Page 260 and 261: 2) We identified 20 documents elabo
Page 262 and 263: estimator, establishing the followi
Page 264 and 265: CLINICAL PRACTICE GUIDELINE FOR EAT
Page 266 and 267: 17. Detecció i orientacions terap
Page 268 and 269: 59. Lo importante es tu vida. No la
Page 270 and 271: 98. Garner DM. Pathogenesis of anor
Page 272 and 273: 141. Wilksch SM, Tiggemann M, Wade
Page 274 and 275: 181. Rivas T, Jiménez M, Bersabé
Page 276 and 277: 224. Fairburn CG, Jones R, Peveler
Page 278 and 279: 262. McCann UD, Agras WS. Successfu
Page 280 and 281: 302. McElroy SL, Casuto LS, Nelson
Page 282 and 283: 341. Hodes M, Timimi S, Robinson P.
Page 284 and 285: 388. Steinhausen HC. The outcome of
show all

CPG for Eating Disorders

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?